Natural occurrence of 2′,5′-linked heteronucleotides in marine sponges

Marine Drugs

Volumn 8, Issue 2, 2010, Pages 235-254

  Lopp, Annika ^a   Reintamm, Tõnu ^a   Kuusksalu, Anne ^a   Tammiste, Indrek ^a   Pihlak, Arno ^a   Kelve, Merike ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

2 ,5 linked heteronucleotides; 2 ,5 oligoadenylate synthetase; Marine sponge; Natural products; OAS

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CYTIDINE TRIPHOSPHATE; GUANOSINE TRIPHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NUCLEOTIDE; PERCHLORIC ACID; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; DEPHOSPHORYLATION; ENZYME SPECIFICITY; NONHUMAN; NUCLEOTIDE METABOLISM; OLIGOMERIZATION; PURINE SYNTHESIS; SPONGE (PORIFERA);

CHONDRILLA NUCULA; MAMMALIA; THENEA MURICATA; VERTEBRATA;

EID: 77649204350     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md8020235     Document Type: Article

References (45)

1. Hovanessian, A.G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2′-5′ oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev. 2007, 18, 351-361.
2. Williams, B.R.; Golgher, R.R.; Kerr, I.M. Activation of a nuclease by pppA2′p5′A2′p5′A in intact cells. FEBS Lett. 1979, 105, 47-52.
3. Hovanessian, A.G.; Wood, J.N. Anticellular and antiviral effects of pppA(2′p5′A)n. Virology 1980, 101, 81-90.
4. Zhou, A; Hassel, B.A.; Silverman, R.H. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 1993, 72, 753-765.
5. Kerr, I.M. The 2-5A system: A personal view. J. Interferon Res. 1987, 7, 505-510.
6. Salzberg, S.; Hyman, T.; Turm, H.; Kinar, Y.; Schwartz, Y.; Nir, U.; Lejbkowicz, F.; Huberman, E. Ectopic expression of 2-5A synthetase in myeloid cells induces growth arrest and facilitates the appearance of a myeloid differentiation marker. Cancer Res. 1997, 57, 2732-2740.
7. Player, M.R.; Torrence, P.F. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation. Pharmacol. Ther. 1998, 78, 55-113.
8. Ghosh, A.; Sarkar, S.N.; Sen, G.C. Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. Virology 2000, 266, 319-328.
9. Chawla-Sarkar, M.; Lindner, D.J.; Liu, Y.F.; Williams, B.R.; Sen, G.C.; Silverman, R.H.; Borden, E.C. Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003, 8, 237-249.
10. Ghosh, A.; Sarkar, S.N.; Rowe, T.M.; Sen, G.C. A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J Biol Chem. 2001, 276, 25447-25455.
11. McAveney, K.M.; Book, M.L.; Ling, P.; Chebath, J.; Yu-Lee, L. Association of 2′,5′-oligoadenylate synthetase with the prolactin (PRL) receptor: alteration in PRL-inducible stat1 (signal transducer and activator of transcription 1) signaling to the IRF-1 (interferon-regulatory factor 1) promoter. Mol Endocrinol. 2000, 14, 295-306.
12. Castora, F.J.; Erickson, C.E.; Kovács, T.; Lesiak, K.; Torrence, P.F. 2′,5′-Oligoadenylates inhibit relaxation of supercoiled DNA by calf thymus DNA topoisomerase I. J Interferon Res. 1991, 11, 143-149.
13. Justesen, J.; Ferbus, D.; Thang, M.N. Elongation mechanism and substrate specificity of 2′,5′-oligoadenylate synthetase. Proc. Natl. Acad. Sci. USA 1980, 77, 4618-4622.
14. Justesen, J.; Ferbus, D.; Thang, M.N. 2′5′ oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2′5′ oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res. 1980, 8, 3073-3085.
15. Ferbus, D.; Justesen, J.; Besançon, F.; Thang, M.N. The 2′5′ oligoadenylate synthetase has a multifunctional 2′5′ nucleotidyl-transferase activity. Biochem. Biophys. Res. Commun. 1981, 100, 847-856.
16. Marié, I.; Blanco, J.; Rebouillat, D.; Hovanessian, A.G. 69-kDa and 100-kDa isoforms of interferon-induced (2′-5′)oligoadenylate synthetase exhibit differential catalytic parameters. Eur. J. Biochem. 1997, 248, 558-566.
17. Voet, D.; Voet, J.G. Biochemistry; J. Wiley and Sons: New York, NY, USA, 1990.
18. Sperling, J.; Chebath, J.; Arad-Dann, H.; Offen, D.; Spann, P.; Lehrer, R.; Goldblatt, D.; Jolles, B.; Sperling, R. Possible involvement of (2′-5′)oligoadenylate synthetase activity in pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 1991, 88, 10377-10381.
19. Besse, S.; Rebouillat, D.; Marie, I.; Puvion-Dutilleul, F.; Hovanessian, A.G. Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells. Exp. Cell Res. 1998, 239, 379-392.
20. Drocourt, J.L.; Dieffenbach, C.W.; Ts'o, P.O.; Justesen, J.; Thang, M.N. Structural requirements of (2′-5′) oligoadenylate for protein synthesis inhibition in human fibroblasts. Nucleic Acids Res. 1982, 10, 2163-2174.
21. Justesen, J.; Hartmann, R.; Kjeldgaard, N.O. Gene structure and function of the 2′-5′-oligoadenylate synthetase family. Cell. Mol. Life Sci. 2000, 57, 1593-1612.
22. Holm, L.; Sander, C. DNA polymerase β belongs to an ancient nucleotidyltransferase superfamily. Trends Biochim. Sci. 1995, 20, 345-347.
23. Aravind, A.; Koonin, E. DNA polymerase β-like nucleotidyltransferase superfamily: identification of three new families, classification and evolutionary history. Nucleic Acids Res. 1999, 27, 1609-1618.
24. Martin, G.; Keller, W. RNA-specific ribonucleotidyltransferases. RNA 2007, 11, 1834-1849.
25. Torralba, S.; Sojat, J.; Hartmann, R. 2′-5′ oligoadenylate synthetase shares active site architecture with the archaeal CCA-adding enzyme. Cell Mol Life Sci. 2008, 65, 2613-2620.
26. Kjaer, K.H.; Poulsen, J.B.; Reintamm, T.; Saby, E.; Martensen, P.M.; Kelve, M.; Justesen, J. Evolution of the 2′-5′-Oligoadenylate Synthetase Family in Eukaryotes and Bacteria. J Mol Evol. 2009, 69, 612-624.
27. Mashimo, T.; Glaser, P.; Lucas, M.; Simon-Chazottes, D.; Ceccaldi, P.E.; Montagutelli, X.; Desprès, P.; Guénet, J.L. Structural and functional genomics and evolutionary relationships in the cluster of genes encoding murine 2′,5′-oligoadenylate synthetases. Genomics 2003, 82, 537-552.
28. Venkatesh, B.; Kirkness, E.F.; Loh, Y.H.; Halpern, A.L.; Lee, A.P.; Johnson, J.; Dandona, N.; Viswanathan, L.D.; Tay, A.; Venter, J.C.; Strausberg, R.L.; Brenner, S. Survey sequencing and comparative analysis of the elephant shark (Callorhinchus milii) genome. PLoS Biol. 2007, 5, e101.
29. Kuusksalu, A.; Pihlak, A.; Müller, W.E.; Kelve, M. The (2′-5′)oligoadenylate synthetase is present in the lowest multicellular organisms, the marine sponges. Demonstration of the existence and identification of its reaction products. Eur. J. Biochem. 1995, 232, 351-357.
30. Kuusksalu, A.; Subbi, J.; Pehk, T.; Reintamm, T.; Müller, W.E.; Kelve, M. Identification of the reaction products of (2′-5′) oligoadenylate synthetase in the marine sponge. Eur. J. Biochem. 1998, 257, 420-426.
31. Wiens, M.; Kuusksalu, A.; Kelve, M.; Müller, W.E. Origin of the interferon-inducible (2′-5′)oligoadenylate synthetases: Cloning of the (2′-5′)oligoadenylate synthetase from the marine sponge Geodia cydonium. FEBS Lett. 1999, 462, 12-18.
32. Grebenjuk, V.A.; Kuusksalu, A.; Kelve, M.; Schütze, J.; Schröder, H.C.; Müller, W.E. Induction of (2′-5′) oligoadenylate synthetase in the marine sponges Suberites domuncula and Geodia cydonium by the bacterial endotoxin lipopolysaccharide. Eur. J. Biochem. 2002, 269, 1382-1392.
33. Müller, W.E.G.; Müller, I.M. Origin of the metazoan immune system: Identification of the molecules and their functions in sponges. Integr. Comp. Biol. 2003, 43, 281-292.
34. Schröder, H.C.; Natalio, F.; Wiens, M.; Tahir, M.N.; Shukoor, M.I.; Tremel, W.; Belikov, S.I.; Krasko, A.; Müller, W.E.G. The 2′-5′-oligoadenylate in the lowest metazoa: isolation, cloning, expression and functional activity in the sponge Lubomirskia baicalensis. Mol. Immunol. 2008, 45, 945-953.
35. Päri, M.; Kuusksalu, A.; Lopp, A.; Reintamm, T.; Justesen, J.; Kelve, M. Expression and characterization of recombinant 2′,5′- oligoadenylate synthetase from the marine sponge Geodia cydonium. FEBS J. 2007, 274, 3462-3474.
36. Reintamm, T.; Kuusksalu, A.; Metsis, M.; Päri, M.; Vallmann, K.; Lopp, A.; Justesen, J.; Kelve, M. Sponge OAS has a distinct genomic structure within the 2-5A synthetase family. Mol. Genet. Genomics 2008, 280, 453-466.
37. Schröder, H.C.; Wiens, M.; Kuusksalu, A.; Kelve, M.; Müller, W.E.G. Modulation of 2′-5′ oligoadenylate synthetase by environmental stress in marine sponge Geodia cydonium. Environ. Toxicol. Chem. 1997, 16, 1403-1409.
38. Robalino, J.; Bartlett, T.C.; Chapman, R.W.; Gross, P.S.; Browdy, C.L.; Warr, G.W. Double-stranded RNA and antiviral immunity in marine shrimp: inducible host mechanisms and evidence for the evolution of viral counter-responses. Dev. Comp. Immunol. 2007, 31, 539-547.
39. Reintamm, T.; Lopp, A.; Kuusksalu, A.; Subbi, J.; Kelve, M. Qualitative and quantitative aspects of 2-5A synthesizing capacity of different marine sponges. Biomol. Eng. 2003, 20, 389-399.
40. Wells, J.A.; Swyryd, E.A.; Stark, G.R. An improved method for purifying 2′5′-oligoadenylate synthetases. J. Biol. Chem. 1984, 259, 1363-1370.
41. Amantonico, A.; Urban, P.L.; Zenobi, R. Facile analysis of metabolites by capillary electrophoresis coupled to matrix-assisted laser desorption/ ionization mass spectrometry using target plates with polysilazane nanocoating and grooves. Analyst 2009, 134, 1536-1540.
42. Cayley, P.J.; Kerr, I.M. Synthesis, characterisation and biological significance of (2′-5′)oligoadenylate derivatives of NAD+, ADP-ribose and adenosine(5′)tetraphospho(5′)adenosine. Eur. J. Biochem. 1982, 122, 601-608.
43. Seth, M.; Thurlow, D.L.; Hou, Y.M. Poly(C) synthesis by class I and class II CCA-adding enzymes. Biochemistry 2002, 41, 4521-4532.
44. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
45. Lopp, A.; Kuusksalu, A.; Reintamm, T.; Müller, W.E.G.; Kelve, M. 2′,5′-oligoadenylate synthetase from a lower invertebrate, the marine sponge Geodia cydonium, does not need dsRNA for its enzymatic activity. Biochim. Biophys. Acta 2002, 1590, 140-149.